Tackling the Problem Head On: Key Considerations for CMV in the Post-Transplant Setting: A Care Team Forum®

Program Overview

Cytomegalovirus (CMV) is a formidable pathogen after solid organ or hematopoietic cell transplant. During this engaging activity, Drs. Humar and Papanicolaou and an experienced patient discuss best practices for CMV prevention and treatment after transplantation. Learn how to incorporate newer therapeutic options for CMV to improve outcomes in your transplant patients.

Credit Expired

Target Audience

Critical care, hematology-oncology, hospitalist, infectious disease, nephrology, pharmacy, primary care, and surgery

Educational Objectives

Upon completion of this activity, participants should be better able to:

Identify patients who are at risk for cytomegalovirus (CMV) infection in the post-transplant setting
Describe the burden associated with CMV infection and its impact on post-transplant outcomes
Utilize prophylactic and preemptive antiviral therapies for the management of CMV in transplant recipients
Integrate new antiviral therapies into management regimens for transplant recipients, including those who develop treatment-refractory or drug-resistant CMV

Activity Faculty

Atul Humar, MD, FRCPC, FAST

Professor, Department of Medicine
University of Toronto
R. Fraser Elliott Chair, Transplantation
University Health Network
Director, University of Toronto Transplant Institute
Toronto, ON, Canada

Genovefa Papanicolaou, MD

Infectious Disease Service
Memorial Sloan Kettering Cancer Center
Professor, Medicine
Weill Cornell Medical College, Cornell University
New York, NY, United States

Featured RMEI CE Activities – Earn CE Credit(s)

Tackling the Problem Head On: Key Considerations for CMV in the Post-Transplant Setting: A Care Team Forum®

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Atul Humar, MD, FRCPC, FAST

Genovefa Papanicolaou, MD

Beyond the Guidelines for CMV: Clinical Perspectives on Challenging Cases Post-Transplant: A Clinical Forum®

New Horizons in Food Allergy: Best Practices & Treatment Advances for Unmet Needs: A Clinical Transfers®

Immunotherapy for NMSC: Key Insights for Oncology, Dermatology, and Infusion Nurses: A Clinical Transfers®

Subscribe